FDA.reportPublic FDA data

Sephience 250 MG Oral Powder

RxCUI
2723071
RxNorm name
Sephience 250 MG Oral Powder
Display name
Sephience 250 MG Oral Powder
Full name
Sephience 250 MG Oral Powder
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:53

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
SephienceSEPIAPTERINPTC Therapeutics Inc.32ac719c-49f0-4105-9c46-18c19583a5c22026-04-24Warnings, Adverse reactionsExact identifier
rxcui: 2723071
SephienceSEPIAPTERINallphamed Pharbil Arzneimittel GmbH9fabfee2-9488-4d03-b203-8fa50f9a7f552025-10-02Warnings, Adverse reactionsExact identifier
rxcui: 2723071

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
32ac719c-49f0-4105-9c46-18c19583a5c2Sephience 250 MG Oral PowderSY6These highlights do not include all the information needed to use SEPHIENCE safely and effectively. See full prescribing information for SEPHIENCE. SEPHIENCE (sepiapterin) oral powder Initial U.S. Approval: 202520260424
32ac719c-49f0-4105-9c46-18c19583a5c2sepiapterin 250 MG Oral Powder [Sephience]SBD6These highlights do not include all the information needed to use SEPHIENCE safely and effectively. See full prescribing information for SEPHIENCE. SEPHIENCE (sepiapterin) oral powder Initial U.S. Approval: 202520260424
32ac719c-49f0-4105-9c46-18c19583a5c2Sephience 250 MG Oral PowderPSN6These highlights do not include all the information needed to use SEPHIENCE safely and effectively. See full prescribing information for SEPHIENCE. SEPHIENCE (sepiapterin) oral powder Initial U.S. Approval: 202520260424
9fabfee2-9488-4d03-b203-8fa50f9a7f55sepiapterin 250 MG Oral Powder [Sephience]SBD1These highlights do not include all the information needed to use SEPHIENCE safely and effectively. See full prescribing information for SEPHIENCE. SEPHIENCE (sepiapterin) oral powder Initial U.S. Approval: 202520251002
9fabfee2-9488-4d03-b203-8fa50f9a7f55Sephience 250 MG Oral PowderPSN1These highlights do not include all the information needed to use SEPHIENCE safely and effectively. See full prescribing information for SEPHIENCE. SEPHIENCE (sepiapterin) oral powder Initial U.S. Approval: 202520251002
9fabfee2-9488-4d03-b203-8fa50f9a7f55Sephience 250 MG Oral PowderSY1These highlights do not include all the information needed to use SEPHIENCE safely and effectively. See full prescribing information for SEPHIENCE. SEPHIENCE (sepiapterin) oral powder Initial U.S. Approval: 202520251002